Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
8,187
datasets available to search
ShareScore release 0.7.1
Dataset results
8,187 results for “Lung cancer”
Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov study NCT00589056. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
ClinicalTrials.gov study NCT03703297. IPD Sharing: YES. Countries: 19. Publications: 3.
A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00550173. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy
ClinicalTrials.gov study NCT06688422. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT04005716. IPD Sharing: YES. Countries: 1. Publications: 4.
Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06091943. IPD Sharing: YES. Countries: 3. Publications: 0.
Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00520676. IPD Sharing: Not stated. Countries: 6. Publications: 2.
An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01362296. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00960999. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
ClinicalTrials.gov study NCT02154490. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT01017601. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer
ClinicalTrials.gov study NCT00387660. IPD Sharing: Not stated. Countries: 1. Publications: 1.
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00946712. IPD Sharing: Not stated. Countries: 2. Publications: 2.
M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03840915. IPD Sharing: YES. Countries: 3. Publications: 1.
Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)
ClinicalTrials.gov study NCT05224141. IPD Sharing: YES. Countries: 25. Publications: 1.
Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00826449. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00855894. IPD Sharing: Not stated. Countries: 2. Publications: 1.
BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00098254. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01102231. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations
ClinicalTrials.gov study NCT01342965. IPD Sharing: Not stated. Countries: 3. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.